SENS earnings call for the period ending March 31, 2019.
News & Analysis: Senseonics Holdings, Inc.
The continuous glucose system (CGM) maker posted solid revenue growth but missed Wall Street's revenue and earnings estimates.
SENS earnings call for the period ending December 31, 2018.
Shares popped after the company announced a favorable reimbursement agreement.
These diabetes stocks gained at least 50% in the first half of the year. But can the momentum continue?
These low-priced stocks could generate huge returns. But there are huge risks, too.
With trade tensions heating up between the U.S. and China, here are some things to think about when it comes to the stock market.
Shares jump after the company receives some favorable commentary from a Wall Street analyst.
Shares tumble after management announces the details of a capital raise and preliminary results for the fourth quarter.
Today's secondary stock-offering pricing proposal received a round of applause from the market today.